Continue reading this on our app for a better experience

Open in App
Floating Button
Home Capital Results

Singapore O&G reports 15.5% earnings decline to $2.1 mil on higher operational expenses

Michelle Zhu
Michelle Zhu • 2 min read
Singapore O&G reports 15.5% earnings decline to $2.1 mil on higher operational expenses
SINGAPORE (May 9): Singapore O&G (SOG) has reported earnings of $2.1 million for 1Q19, down 15.5% from $2.5 million a year ago due to higher operational expenses.
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

SINGAPORE (May 9): Singapore O&G (SOG) has reported earnings of $2.1 million for 1Q19, down 15.5% from $2.5 million a year ago due to higher operational expenses.

This translates earnings per share (EPS) of 0.44 cent, down from 0.52 cent in 1Q18 although net asset value (NAV) per share grew to 9.79 cents as at end-March from 9.35 cents as at end-2018.

Revenue for the quarter grew 6.5% on-year to $8.7 million from $8.2 million previously as the group achieved revenue growth across its Obstetrics & Gynaecology (O&G), Cancer-related and Paediatrics segments.

Growth in contributions from these segments collectively helped to offset a revenue decline in the Dermatology segment, which was attributed to an increasingly competitive industry landscape.

Expenses for consumables and medical supplies used rose 21.5% to $1.6 million from $1.3 million previously, mainly due to higher medication sales and consumables used in procedures across all segments.

Employee remuneration expenses grew 19.4% to $3.8 million due to new clinics PAED-Gastro, SOG Dermatology (Gleneagles) and PAED-Glen, as well as a higher incentive bonus for a few specialist medical practitioners.

Meanwhile, depreciation expenses more than doubled $0.5 million from $0.2 million, attributable to depreciation recognised for right-of-use (ROU) assets from the adoption of the SFRS (I) 16 accounting standard.

Other operating expense fell 31.7% to $0.5 million due to lower rental expense arising from the adoption of SFRS (I) 16, offset in part by higher advertising, consultancy fees, office supplies and other administrative expenses.

As at end-March, the group’s cash and cash equivalents stood at $25.1 million compared to $21.5 million as at end-Dec.

“As we continue to see growing demand for our O&G services, we recruited our seventh O&G medical specialist, Dr. Clara Ong in May this year… At the same time, the group is also looking to sharpen the competitive edge of our Dermatology segment to further boost this segment,” says Beh Suan Tiong, executive chairman of SOG.

Shares in SOG closed 1.37% lower at 36 cents on Thursday.

Highlights

Re test Testing QA Spotlight
1000th issue

Re test Testing QA Spotlight

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.